45 related articles for article (PubMed ID: 9129036)
1. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I.
Richardson JH; Höllsberg P; Windhagen A; Child LA; Hafler DA; Lever AM
Blood; 1997 May; 89(9):3303-14. PubMed ID: 9129036
[TBL] [Abstract][Full Text] [Related]
2. The impact of HTLV-1 expression on the 3D structure and expression of host chromatin.
Yaguchi H; Melamed A; Ramanayake S; Kiik H; Witkover A; Bangham CRM
PLoS Pathog; 2024 Mar; 20(3):e1011716. PubMed ID: 38427693
[TBL] [Abstract][Full Text] [Related]
3. Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis.
Joseph A; Cheng X; Harding J; Al-Saleem J; Green P; Veis D; Rauch D; Ratner L
bioRxiv; 2024 May; ():. PubMed ID: 38853836
[TBL] [Abstract][Full Text] [Related]
4. Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors?
Carcone A; Journo C; Dutartre H
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893677
[TBL] [Abstract][Full Text] [Related]
5. Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.
Maksimova V; Panfil AR
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062342
[TBL] [Abstract][Full Text] [Related]
6. Diversity of cell phenotypes among MT-2 cell lines affects the growth of U937 cells and cytokine production.
Nomura H; Umekita K; Hashikura Y; Umeki K; Yamamoto I; Aratake Y; Saito M; Hasegawa H; Yanagihara K; Okayama A
Hum Cell; 2019 Apr; 32(2):185-192. PubMed ID: 30560508
[TBL] [Abstract][Full Text] [Related]
7. RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.
Lin HC; Simon PJ; Ysla RM; Zeichner SL; Brewer G; Rabson AB
Virology; 2017 Aug; 508():7-17. PubMed ID: 28478312
[TBL] [Abstract][Full Text] [Related]
8. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI
J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729
[TBL] [Abstract][Full Text] [Related]
9. Pathways of cell-cell transmission of HTLV-1.
Pique C; Jones KS
Front Microbiol; 2012; 3():378. PubMed ID: 23109932
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter.
Rahman S; Quann K; Pandya D; Singh S; Khan ZK; Jain P
PLoS One; 2012; 7(4):e34490. PubMed ID: 22496815
[TBL] [Abstract][Full Text] [Related]
11. The HTLV-1 Virological Synapse.
Nejmeddine M; Bangham CRM
Viruses; 2010 Jul; 2(7):1427-1447. PubMed ID: 21994688
[TBL] [Abstract][Full Text] [Related]
12. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.
Manuel SL; Schell TD; Acheampong E; Rahman S; Khan ZK; Jain P
J Leukoc Biol; 2009 Nov; 86(5):1205-16. PubMed ID: 19656902
[TBL] [Abstract][Full Text] [Related]
13. How does HTLV-I persist despite a strong cell-mediated immune response?
Asquith B; Bangham CR
Trends Immunol; 2008 Jan; 29(1):4-11. PubMed ID: 18042431
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.
Sibon D; Gabet AS; Zandecki M; Pinatel C; Thête J; Delfau-Larue MH; Rabaaoui S; Gessain A; Gout O; Jacobson S; Mortreux F; Wattel E
J Clin Invest; 2006 Apr; 116(4):974-83. PubMed ID: 16585963
[TBL] [Abstract][Full Text] [Related]
15. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Xie L; Green PL
J Virol; 2005 Dec; 79(23):14536-45. PubMed ID: 16282453
[TBL] [Abstract][Full Text] [Related]
16. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.
Azran I; Schavinsky-Khrapunsky Y; Aboud M
Retrovirology; 2004 Aug; 1():20. PubMed ID: 15310405
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.
Dumais N; Paré ME; Mercier S; Bounou S; Marriot SJ; Barbeau B; Tremblay MJ
J Virol; 2003 Oct; 77(20):11170-9. PubMed ID: 14512564
[TBL] [Abstract][Full Text] [Related]
18. Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression.
Furuta RA; Sugiura K; Kawakita S; Inada T; Ikehara S; Matsuda T; Fujisawa J
J Virol; 2002 Mar; 76(6):2703-13. PubMed ID: 11861837
[TBL] [Abstract][Full Text] [Related]
19. Is human T-cell lymphotropic virus type I really silent?
Asquith B; Hanon E; Taylor GP; Bangham CR
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1013-9. PubMed ID: 11186302
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.
Höllsberg P
Microbiol Mol Biol Rev; 1999 Jun; 63(2):308-33. PubMed ID: 10357853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
